Introduction While guidelines stronglyrecommend dexamethasone in critical COVID-19, the
optimal threshold to initiate corticosteroids in non-critically ill patients with COVID-19 …

Objectives The aim of this study was to evaluate the impact on 30-day mortality of early use
of corticosteroids in COVID-19 patients with supplementary oxygen requirements and …

The optimal timing of initiating corticosteroid treatment in hospitalized patients is unknown.
We aimed to assess the relationship between timing of initial corticosteroid treatment and in …

Objectives To assess whether high-compared with low-dose corticosteroids started upon
hospitalization reduce mortality in patients with severe COVID-19 pneumonia or in …

Purpose Although there is evidence supporting the benefits of corticosteroids in patients
affected with severe coronavirus disease 2019 (COVID-19), there is little information related …

Corticosteroids use in coronavirus disease 2019 (COVID-19) is controversial, especially in
mild to severe patients who do not require invasive/noninvasive ventilation. Moreover, many …

Background Low-dose corticosteroids have been shown to reduce mortality for hypoxic
COVID-19 patients requiring oxygen or ventilatory support (non-invasive mechanical …

Background Reduced mortality at 28 days in patients treated with corticosteroids was
demonstrated, but this result was not confirmed by certain large epidemiological studies. Our …

ABSTRACT INTRODUCTION Hypoxemia in Severe Acute Respiratory Syndrome due to
Novel Coronavirus of 2019 (SARS-CoV-2) is mediated by severe inflammation that may be …

Background Low-dose corticosteroids have been shown to reduce mortality for patients with
COVID-19 requiring oxygen or ventilatory support (non-invasive mechanical ventilation …